Список литературы

1. Yang H., Bocchetta M., Kroczynska B., Elmishad A.G., Chen Y., Liu Z., Bubici C, Mossman B.T., Pass H.I., Testa J.R., Franzoso G., Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis//Proc. Natl. Acad. Sci. USA. 2006. Vol. 103. No 27. P. 10397 - 10402.

2. Carbone M., Kratzke R.A., Testa J.R. Pathogenesis of mesothelioma//Semin. Oncol. 2002. Vol. 29. No 1. P. 2 - 17.

3. Ismail-Khan R., Robinson L.A., Williams Jr C.C., Garrett C.R., Bepler G., Simon G.R. Malignant pleural mesothelioma: a comprehensive review//Cancer Control. 2006. Vol. 13. No 4. P. 255 - 263.

4. Testa J.R., Carbone M. Mesothelioma//Cancer research: an encyclopedic reference /Ed. by M. Schwab. Heidelberg: Springer-Verlay, 2002. P. 861 - 865.

5. Battifora H., McCaughey W.T.E. Tumor of serosal membranes//Atlas of tumor pathology/Ed. by J. Rosai, L.H. Sobin. Washington, 1995.

6. Boutin C, Schlesser M., Frenay C. et al. Malignant pleural mesothelioma//Europ. Respir. J. - 1998. - Vol. 12. - P. 972 - 981

7. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. (WHO). Histological typing of lung and pleural tumour//Berlin, Springer - 1999 - ISBN - 13: 978-3-540-65219-9

8. Hierholzer J. et al. MRI and CT in the Differential Diagnosis of Pleural Disease//Chest. - 2000. - Vol. 118. - P. 604 - 609.

9. Schouwink J.H., Kool L.S., Rutgers E.J. et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma//Ann. Thorac. Surg. - 2003. - Vol. 75.- P. 1715 - 1719.

10. Heelan R.T. et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging//AJR. Amer. J. Roent-genol. - 1999. - Vol. 172. - P. 1039 - 1047.

11. Hierholzer J. et al. MRI and CT in the Differential Diagnosis of Pleural Disease//Chest. - 2000. - Vol. 118. - P. 604 - 609.

12. Maziak D.E., Gagliardi A., Haynes A.E. et al. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary//Lung. Cancer. - 2005. - Vol. 48 (2). - P. 157 - 169.

13. ORourke N, Garcia JC, Paul J et al. A randomized controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007; 84: 18 - 22.

14. Castagneto B, Bota M, Aitini E et al. Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma. Ann Oncol 2008; 19: 370 - 373.

15. Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636 - 2644.

16. Nakas A, Ucar M, Edwards JG, Waller DA. The role of video-assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83 - 88.

17. Vorobiof D.A., Mafafo K. Malignant pleural mesothelioma: medical treatment update//Clin. Lung Cancer. 2009. Vol. 10. No 2. P. 112 - 117.

18. Robinson B.W., Lake R.A. Advances in Malignant Mesothelioma//New. Engl. J. Med. - 2005. - Vol. 353. - P. 1591 - 603.

19. Nico van Zandwijk Guidelines for the diagnosis and treatment of malignant pleural mesothelioma/J Thorac Dis. 2013 Dec; 5(6): E254 - E307.//Nico van Zandwijk, (https://www.ncbi.nlm.nih.gov/pubmed/?term=van%20Zandwijk%20N%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Christopher Clarke, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Clarke%20C%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Douglas Henderson, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Henderson%20D%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)A. William Musk, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Musk%20AW%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Kwun Fong, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Fong%20K%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Anna Nowak, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Nowak%20A%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Robert Loneragan, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Loneragan%20R%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Brian McCaughan, (https://www.ncbi.nlm.nih.gov/pubmed/?term=McCaughan%20B%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Michael Boyer, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Boyer%20M%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Malcolm Feigen, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Feigen%20M%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)David Currow, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Currow%20D%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Penelope Schofield, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Schofield%20P%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Beth Ivimey Nick Pavlakis, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Nick%20Pavlakis%20BI%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Jocelyn McLean, (https://www.ncbi.nlm.nih.gov/pubmed/?term=McLean%20J%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Henry Marshall, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Marshall%20H%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Steven Leong, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Leong%20S%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Victoria Keena, and (https://www.ncbi.nlm.nih.gov/pubmed/?term=Keena%20V%5BAuthor%5D&cauthor=true&cauthor_uid=24416529)Andrew Penman (https://www.ncbi.nlm.nih.gov/pubmed/?term=Penman%20A%5BAuthor%5D&cauthor=true &cauthor_uid=24416529)